Context Therapeutics Price Chart
Context Therapeutics Volume Chart
Context Therapeutics Market Segments
Premarket
-0.02(-0.66%)
| Open | $3.01 |
|---|---|
| Close | $2.99 |
| Low | $2.99 |
| Low Change | -0.02 (-0.66%) |
| High | $3.01 |
| High Change | +0.00 (+0.00%) |
| Range | $0.02 |
| Volume | 500 |
| Dollar Volume | $1.50K |
After Hours Yesterday
+0.02(+0.67%)
| Open | $3.00 |
|---|---|
| Close | $3.02 |
| Low | $3.00 |
| Low Change | 0.00 (0.00%) |
| High | $3.06 |
| High Change | +0.06 (+2.00%) |
| Range | $0.06 |
| Volume | 8.205K |
| Dollar Volume | $24.78K |
Regular Trading Hours Yesterday
-0.27(-8.13%)
| Open | $3.32 |
|---|---|
| Close | $3.05 |
| Low | $3.02 |
| Low Change | -0.30 (-9.04%) |
| High | $3.62 |
| High Change | +0.30 (+9.04%) |
| Range | $0.60 |
| Volume | 1.701M |
| Dollar Volume | $5.19M |
Premarket Yesterday
-0.01(-0.33%)
| Open | $3.30 |
|---|---|
| Close | $3.29 |
| Low | $3.15 |
| Low Change | -0.15 (-4.55%) |
| High | $3.46 |
| High Change | +0.16 (+4.85%) |
| Range | $0.31 |
| Volume | 10.943K |
| Dollar Volume | $35.99K |
Context Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $3.12 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.95 |
| 20 Day Moving Average (SMA20) | $2.64 |
| 50 Day Moving Average (SMA50) | $2.23 |
| 100 Day Moving Average (SMA100) | $1.69 |
| 200 Day Moving Average (SMA200) | $1.25 |
Context Therapeutics Statistics
| Average Volume (30 Days) | 1.3M |
|---|---|
| P/E Ratio (Current) | -11.59 |
| EPS (Current) | -$0.29 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$22.38M |
| Cash Ratio | 12.75 |
| Current Ratio | 13.10 |
| Quick Ratio | 13.10 |
| Debt to Equity | 0.00 |
| Enterprise Value | $231.78M |
| EV to EBITDA | -7.68 |
| EV to Sales | — |
| Price to Book | 4.22 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.33% |
| Return on Equity | -0.36% |
Context Therapeutics Stock Splits
There have been no stock splits for Context Therapeutics (CNTX).
Context Therapeutics Dividends
There have been no dividends for Context Therapeutics (CNTX).